Andrew S Lindzon

Executive

CA·SEDI

Revive Therapeutics Ltd.

Total declarations

Company

▲ Purchases (1 ops.)

€3,385

▼ Sales (0 ops.)

—

Latest filing published 11 Jul 2024 for Revive Therapeutics Ltd., €3,385.

Filing timeline

BuySale

Andrew S Lindzon

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Andrew S Lindzon: trading record in brief

Our data holds just one disclosure by Andrew S Lindzon, dated 11 July 2024, reporting an open-market purchase worth €3,385 in Revive Therapeutics Ltd. Further filings will be added here. Source: insider filings from SEDI. Past trades are no guide to future returns.

Companies and markets linked to Andrew S Lindzon

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Revive Therapeutics Ltd. (CA)

Declarations1 total

▲

Andrew S Lindzon

4 - Director of IssuerExecutives10 Jul 2024Revive Therapeutics Ltd.

4,995 CAD19SEDI

333,000 shares@ CA$0.015100.0% of flowCommon SharesTSXSEDI:4346633

Canonical exit: 8 Oct 2024 (T+90)

1 of 1 declaration

Andrew S Lindzon

Insider track record

Andrew S Lindzon: trading record in brief

Companies and markets linked to Andrew S Lindzon

Related entities

Andrew S Lindzon

Insider track record

Andrew S Lindzon: trading record in brief

Companies and markets linked to Andrew S Lindzon

Related entities